Authors
Brian P Conlon, Ernesto S Nakayasu, Laura E Fleck, Michael D LaFleur, Vincent M Isabella, K Coleman, Steven N Leonard, Richard D Smith, Joshua N Adkins, Kim Lewis
Publication date
2013/11/21
Journal
Nature
Volume
503
Issue
7476
Pages
365-370
Publisher
Nature Publishing Group UK
Description
Chronic infections are difficult to treat with antibiotics but are caused primarily by drug-sensitive pathogens. Dormant persister cells that are tolerant to killing by antibiotics are responsible for this apparent paradox. Persisters are phenotypic variants of normal cells and pathways leading to dormancy are redundant, making it challenging to develop anti-persister compounds. Biofilms shield persisters from the immune system, suggesting that an antibiotic for treating a chronic infection should be able to eradicate the infection on its own. We reasoned that a compound capable of corrupting a target in dormant cells will kill persisters. The acyldepsipeptide antibiotic (ADEP4) has been shown to activate the ClpP protease, resulting in death of growing cells. Here we show that ADEP4-activated ClpP becomes a fairly nonspecific protease and kills persisters by degrading over 400 proteins, forcing cells to self-digest. Null …
Total citations
20132014201520162017201820192020202120222023202425570798477737578705227
Scholar articles